On August 26, 2023, the Board of Directors of Omega Therapeutics, Inc. elected Michelle C. Werner as a Class I director of the Company and appointed Ms. Werner as a member of the Board?s Nominating and Corporate Governance Committee, effective August 28, 2023. On the Effective Date, Noubar B. Afeyan, Ph.D., submitted his resignation as a member of and Chair of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.41 USD | +1.26% | +22.96% | -19.93% |
05-06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.93% | 133M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Omega Therapeutics, Inc. Announces Board Changes